bexarotene has been researched along with acitretin in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bair, SM; Cherpelis, BS; Glass, LF; Marquez, C; Smithberger, E | 1 |
| Farley-Loftus, R; Latkowski, JA; Mandal, R | 1 |
| Cheeley, J; DeLong, LK; Parker, SR; Sahn, RE | 1 |
| Carlton, SM; Clark, RB; Du, G; Du, J; Hu, H; Luo, J; Qian, A; Walters, ET; Yang, Q; Yin, S; Yu, W; Zhou, S | 1 |
| Gunia-Krzyżak, A; Marona, H; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D | 1 |
| Bunch, C; Jäger, M; Schmitt, J; Valipour, A; Weberschock, T; Wu, P | 1 |
| Aquino, C; Avallone, G; Boskovic, S; Fava, P; Macagno, N; Quaglino, P; Ribero, S; Roccuzzo, G | 1 |
3 review(s) available for bexarotene and acitretin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Systemic retinoids for chemoprevention of non-melanoma skin cancer in high-risk patients.
Topics: Acitretin; Anticarcinogenic Agents; Bexarotene; Humans; Risk; Skin Neoplasms; Tetrahydronaphthalenes | 2010 |
Interventions for mycosis fungoides.
Topics: Acitretin; Antineoplastic Agents; Bexarotene; Combined Modality Therapy; Humans; Immunologic Factors; Interferon-alpha; Mycosis Fungoides; Neoplasm Staging; Photochemotherapy; Photopheresis; PUVA Therapy; Randomized Controlled Trials as Topic; Skin Neoplasms | 2020 |
6 other study(ies) available for bexarotene and acitretin
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Poikilodermatous mycosis fungoides.
Topics: Acitretin; Antineoplastic Agents; Bexarotene; Female; Humans; Hydroxamic Acids; Hypopigmentation; Immunophenotyping; Interferon-alpha; Middle Aged; Mycosis Fungoides; Skin Neoplasms; Tetrahydronaphthalenes; Treatment Outcome; Ultraviolet Therapy; Vorinostat | 2010 |
Acitretin for the treatment of cutaneous T-cell lymphoma.
Topics: Acitretin; Adult; Aged; Aged, 80 and over; Bexarotene; Female; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Mycosis Fungoides; Retrospective Studies; Sezary Syndrome; Skin Neoplasms; Tetrahydronaphthalenes; Treatment Outcome | 2013 |
Retinoids activate the irritant receptor TRPV1 and produce sensory hypersensitivity.
Topics: Acitretin; Action Potentials; Animals; Benzoates; Bexarotene; Binding Sites; Calcitonin Gene-Related Peptide; Edema; Ganglia, Spinal; HEK293 Cells; Hindlimb; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Molecular; Nicotinic Acids; Nociception; Nociceptors; Receptors, Retinoic Acid; Retinoids; Signal Transduction; Tetrahydronaphthalenes; TRPV Cation Channels | 2013 |
Skin metabolism established with the use of MetaSite for selected retinoids employed in topical and systemic treatment of various skin disorders and found in cosmeceuticals.
Topics: Acitretin; Adapalene; Administration, Topical; Bexarotene; Cosmeceuticals; Cytochrome P-450 Enzyme System; Humans; Hydroxylation; Inactivation, Metabolic; Retinoids; Skin; Skin Diseases; Software; Structure-Activity Relationship; Tetrahydronaphthalenes; Vitamin A | 2015 |
Time to next treatment and safety assessment in cutaneous-T-cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin.
Topics: Acitretin; Anticarcinogenic Agents; Bexarotene; Humans; Lymphoma, T-Cell, Cutaneous; Retrospective Studies; Skin Neoplasms; Tetrahydronaphthalenes | 2022 |